Comparison of LH-RH Analogue 1-Month Depot and 3-Month Depot by Their Hormone Levels and Pharmacokinetic Profile in Patients with Advanced Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|60|1|9-17

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.60, Iss.1, 1998-03, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cryoablation of Localized Prostate Cancer: Neoadjuvant Downsizing of Prostate Cancer with LH-RH Analogue Depot before Cryosurgery

By  

Urologia Internationalis, Vol. 60, Iss. 1, 1998-03 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Leuprorelin 1-Month Depot as Neoadjuvant Therapy for Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 2, 1998-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial

By  

Urologia Internationalis, Vol. 70, Iss. 4, 2003-05 ,pp. : 316-320

Karger

Access to resources Recommend Favorite

Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results

By  

Urologia Internationalis, Vol. 60, Iss. 2, 1998-04 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite